PharmaZell, a leading supplier of highly resilient and specialty APIs, and Novasep, a major CDMO focused on complex small molecules and ADCs, have recently announced the closing of their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, leading CDMO and API manufacturer.